TokenPost topic

Gene Therapy

1 TokenPost story is tagged Gene Therapy. The newest appear first.

Latest Gene Therapy stories

• JPMorgan Initiates Neurogene Coverage With $60 Price Target

  The overweight rating implies 132% upside from the Oct. 7 close. Neurogene shares have fallen about 32% over the past three months.

  Oct 8, 2026, 8:09 AM EDT · Investing